Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	224.95	71.66	171.33	168.15	57.97
Short-Term Investments	2.5	145.37	0.48	0	0
Cash & Cash Equivalents	227.44	217.03	171.82	168.15	57.97
Cash Growth	4.80%	26.31%	2.18%	190.05%	2340.93%
Receivables	17.71	3.58	0.09	0.02	0.04
Inventory	3.11	0	0	0	0
Other Current Assets	7.87	4.77	4.05	2.49	0.02
Total Current Assets	256.13	225.38	175.95	170.66	58.03
Property, Plant & Equipment	3.35	1.53	1.83	1.24	0.28
Long-Term Investments	0.63	0.37	0	0	0
Goodwill and Intangibles	3.87	0	0	0	0
Other Long-Term Assets	1.51	0.59	1.13	0.08	0.01
Total Long-Term Assets	9.36	2.49	2.96	1.32	0.29
Total Assets	265.49	227.86	178.91	171.97	58.32
Accounts Payable	23.69	9.91	8.68	4.35	0.52
Other Current Liabilities	13.25	5.52	2.8	1.04	0.3
Total Current Liabilities	36.94	15.43	11.48	5.39	0.82
Long-Term Debt	29.82	19.43	0	0	0
Other Long-Term Liabilities	1.75	0.1	0.7	0.61	0.1
Total Long-Term Liabilities	31.57	19.53	0.7	0.61	0.1
Total Liabilities	68.5	34.96	12.18	5.99	0.92
Total Debt	29.82	19.43	0	0	0
Debt Growth	53.44%	-	-	-	-
Retained Earnings	-244.66	-108.76	-46.67	-32.85	-6.03
Comprehensive Income	-0	-0.07	0	0	0
Shareholders' Equity	196.99	192.9	166.73	165.98	-6.01
Net Cash / Debt	197.62	197.59	171.82	168.15	57.97
Net Cash / Debt Growth	0.02%	15.00%	2.18%	190.05%	2340.93%
Net Cash Per Share	6.73	8.03	8.36	27.09	24.54
Working Capital	219.2	209.95	164.47	165.27	57.21
Book Value Per Share	6.70	7.83	8.11	26.74	-2.54

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).